Drug Early Warning from Re-Testing Biological Samples

The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from public nonprofit institutions/organizations (includes institutions of higher education and hospitals) to perform research and analysis of data to inform drug policy.

This project


seeks to further refine a methodology for obtaining drug early warning indicators from expanded testing of urine samples that were previously collected and tested as part of an existing drug test protocol.

This method was initially developed using local criminal justice populations – including persons in pre-trial or lock-up, parolees or probationers, and drug court participants.

Similar methodology is promising for use in other venues, such as in trauma units and emergency departments, where biological samples are often collected from patients.

Before the specimens are discarded, the project will re-test them for an expanded panel of drugs, including synthetic cannabinoids, to determine what old and new illicit drugs are detected or missed by conventional testing protocols, and how the drug patterns might vary by subpopulation and geography.

By passing the expense of collecting the original specimens and re-using those that have already been tested with known results yields a relatively inexpensive and timely picture of emerging drugs in a given subpopulation and locality.

ONDCP expects to continue to engage the laboratory testing services of the Armed Forces Medical Examiner System (AFMES) at no charge to further minimize project costs.

Agency: Office of National Drug Control Policy

Office: None

Estimated Funding: $100,000

Who's Eligible

Obtain Full Opportunity Text:
Not Available

Additional Information of Eligibility:
ONDCP encourages applications from public nonprofit institution/organization (includes institutions of higher education and hospitals).

Applicants must have expert knowledge and extensive experience in conducting research and analysis.

Current awardee is eligible to apply for this funding opportunity.

Full Opportunity Web Address:

darren neelyIT specialistPhone 2023955530

Agency Email Description:
email for electronic access problems

Agency Email:

Date Posted:

Application Due Date:

Archive Date:

Co-founders William Mann and David Mravyan devised the Sensimat during a mandatory project for their MBA at the Richard Ivey School of Business in Canada. Sensimat is a device that helps manage and assess pressure among wheelchair users.

Not for Profit Jobs in Nebraska

  Executive Director Jobs
  Substance Abuse Jobs
  Program Director Jobs
  Executive Director Jobs
  Social Services Jobs

More Federal Domestic Assistance Programs

Snow Survey and Water Supply Forecasting | Commodity Futures Reparations Claims | Employment Discrimination_Title I of The Americans with Disabilities Act | 93.712 ARRA IMMUNIZATION | Transformation Initiative Research Grants: Demonstration and Related Small Grants |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy

Edited by: Michael Saunders

© 2004-2023 Copyright Michael Saunders